Skip to main content

Cefiderocol IV

Permitted Indications

For the treatment of adults with severe drug-resistant infections caused by gram-negative bacteria, including, but not limited to, infections caused by OXA-48 carbapenemase-producing Enterobacterales

  • only on the advice of a Consultant/Specialist Microbiologist or Infectious Disease Specialist and,
  • only if the infection is susceptible to cefiderocol sulfate tosylate and not susceptible to other suitable antibiotics; or if susceptibility results are not available but the infection needs urgent treatment and is expected to be susceptible to cefiderocol sulfate tosylate but not to other suitable antibiotics.